MREO — MEREO BIOPHARMA GROUP PLC

Ownership history in Caption Management, LLC  ·  7 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in MEREO BIOPHARMA GROUP PLC (MREO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2025 Q2)
Avg. % of fund
0.01%
First filed
2025 Q1
Last filed
2025 Q4
Quarters held
7
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 50,000 -139,914 -73.7% 0.00% $21K $0.42
2025 Q3 REDUCED 189,914 -190,586 -50.1% 0.00% $391K $2.06
2025 Q3 ADDED 380,500 +182,901 +92.6% 0.01% $784K $2.06
2025 Q2 REDUCED 197,599 -239,901 -54.8% 0.01% $535K $2.71
3 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    MREO price (monthly, adj. close)

Other funds also holding MREO

As of 2025 Q4 — sorted by position size

683 Capital Management, LLC 3Y 7Y 0.27% Tejara Capital Ltd 3Y 0.21% EcoR1 Capital, LLC 3Y 7Y 0.15% LUMINUS MANAGEMENT LLC 3Y 7Y 0.14% Rangeley Capital, LLC 0.13% Monaco Asset Management SAM 3Y 0.11% Rubric Capital Management LP 3Y 7Y 0.08% EntryPoint Capital, LLC 0.07% Knott David M Jr 3Y 0.06% Logos Global Management LP 3Y 0.05%
← Back to Caption Management, LLC Holdings